📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TCR2 Therapeutics

1.1 - Company Overview

TCR2 Therapeutics Logo

TCR2 Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a unique proprietary TRuC™ platform developed by a discovery-stage pharmaceutical company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TCR2 Therapeutics

Theseus Pharmaceuticals Logo

Theseus Pharmaceuticals

HQ: United States Website
  • Description: Provider of technology-based pharmaceutical offerings.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theseus Pharmaceuticals company profile →
Mirati Therapeutics Logo

Mirati Therapeutics

HQ: Canada Website
  • Description: Provider of novel cancer therapeutics in clinical development and commercialization; product candidates include MGCD265, an oral, multi-targeted kinase inhibitor targeting the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mirati Therapeutics company profile →
MabVax Therapeutics Logo

MabVax Therapeutics

HQ: United States Website
  • Description: Provider of proprietary anti-cancer immunotherapies as a biopharmaceutical company focused on their commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MabVax Therapeutics company profile →
WntResearch Logo

WntResearch

HQ: Sweden Website
  • Description: Provider of anti-metastatic cancer therapies targeting WNT5A signaling. Pipeline includes Foxy-5, a peptide drug candidate that mimics WNT5A to reduce cancer cell mobility and spread (Phase I; reconstitutes Wnt-5a effects in breast cancer cells), and Box-5, a peptide in preclinical development that antagonizes Wnt-5a.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WntResearch company profile →
FogPharma Logo

FogPharma

HQ: United States Website
  • Description: Provider of precision medicines based on Helicons, a new class combining antibody-like targeting with broad tissue distribution and intracellular target engagement of small molecules; pipeline includes FOG-001, a first-in-class TCF-blocking β-catenin inhibitor (Phase 1/2), β-catenin and ERG degraders, an ERG/DNA binding inhibitor (discovery), and Helicon-enabled alpha radioligand therapies (hit identification).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full FogPharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TCR2 Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TCR2 Therapeutics

2.2 - Growth funds investing in similar companies to TCR2 Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TCR2 Therapeutics

4.2 - Public trading comparable groups for TCR2 Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TCR2 Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TCR2 Therapeutics

What does TCR2 Therapeutics do?

TCR2 Therapeutics is a provider of a unique proprietary TRuC™ platform developed by a discovery-stage pharmaceutical company.

Who are TCR2 Therapeutics's competitors?

TCR2 Therapeutics's competitors and similar companies include Theseus Pharmaceuticals, Mirati Therapeutics, MabVax Therapeutics, WntResearch, and FogPharma.

Where is TCR2 Therapeutics headquartered?

TCR2 Therapeutics is headquartered in United States.

How many employees does TCR2 Therapeutics have?

TCR2 Therapeutics has 1,000 employees 🔒.

When was TCR2 Therapeutics founded?

TCR2 Therapeutics was founded in 2010 🔒.

What sector and industry vertical is TCR2 Therapeutics in?

TCR2 Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TCR2 Therapeutics

Who are the top strategic acquirers in TCR2 Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in TCR2 Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TCR2 Therapeutics?

Top strategic M&A buyers groups and sectors for TCR2 Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TCR2 Therapeutics's sector and industry vertical

Which are the top PE firms investing in TCR2 Therapeutics's sector and industry vertical?

Top PE firms investing in TCR2 Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TCR2 Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TCR2 Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TCR2 Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TCR2 Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TCR2 Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TCR2 Therapeutics?

The key public trading comparables and valuation benchmarks for TCR2 Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TCR2 Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TCR2 Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TCR2 Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TCR2 Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TCR2 Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in TCR2 Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TCR2 Therapeutics